<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1093402</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2022.1093402</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Construction of an efficient <italic>Claviceps paspali</italic> cell factory for lysergic acid production</article-title>
<alt-title alt-title-type="left-running-head">Hu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2022.1093402">10.3389/fbioe.2022.1093402</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Mingzhe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Siyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2130203/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Shen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yong</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Shaoxin</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Xuenian</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1432082/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Xuefeng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/87231/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>College of Life Sciences</institution>, <institution>Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Shandong Provincial Key Laboratory of Synthetic Biology</institution>, <institution>Qingdao Institute of Bioenergy and Bioprocess Technology</institution>, <institution>Chinese Academy of Sciences</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Shandong Energy Institute</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Qingdao New Energy Shandong Laboratory</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Institute for Smart Materials and Engineering</institution>, <institution>University of Jinan</institution>, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Shisenhai (Hangzhou) Biopharmaceutical Co., Ltd.</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>University of Chinese Academy of Sciences</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>State Key Lab of New Drug and Pharmaceutical Process</institution>, <institution>Shanghai Institute of Pharmaceutical Industry</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Marine Biology and Biotechnology Laboratory</institution>, <institution>Qingdao National Laboratory for Marine Science and Technology</institution>, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/234264/overview">Xiao-Jun Ji</ext-link>, Nanjing Tech University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2058820/overview">Chengwei Liu</ext-link>, Northeast Forestry University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1973084/overview">Asha Chaubey</ext-link>, Indian Institute of Integrative Medicine (CSIR), India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Shaoxin Chen, <email>sxzlb@263.net</email>; Xuenian Huang, <email>huangxn@qibebt.ac.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship.</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Industrial Biotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>1093402</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Hu, Zhou, Du, Zhang, Tang, Yang, Zhang, Chen, Huang and Lu.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hu, Zhou, Du, Zhang, Tang, Yang, Zhang, Chen, Huang and Lu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lysergic acid (LA) is the key precursor of ergot alkaloids, and its derivatives have been used extensively for the treatment of neurological disorders. However, the poor fermentation efficiency limited its industrial application. At the same time, the hardship of genetic manipulation has hindered the metabolic engineering of <italic>Claviceps</italic> strains to improve the LA titer further. In this study, an efficient genetic manipulation system based on the protoplast-mediated transformation was established in the industrial strain <italic>Claviceps paspali</italic>. On this basis, the gene <italic>lpsB</italic> located in the ergot alkaloids biosynthetic gene cluster was deleted to construct the LA-producing cell factory. Plackett-Burman and Box-Behnken designs were used in shaking flasks, achieving an optimal fermentation medium composition. The final titer of LA and iso-lysergic acid (ILA) reached 3.7&#xa0;g&#x00B7;L<sup>&#x2212;1</sup>, which was 4.6&#xa0;times higher than that in the initial medium. Our work provides an efficient strategy for the biosynthesis of LA and ILA and lays the groundwork for its industrial production.</p>
</abstract>
<kwd-group>
<kwd>lysergic acid</kwd>
<kwd>
<italic>Claviceps paspali</italic>
</kwd>
<kwd>metabolic engineering</kwd>
<kwd>medium composition</kwd>
<kwd>fermentation optimization</kwd>
</kwd-group>
<contract-num rid="cn001">2021YFC2102600</contract-num>
<contract-num rid="cn002">U2032139</contract-num>
<contract-num rid="cn003">32170098</contract-num>
<contract-num rid="cn004">2021ZDSYS02</contract-num>
<contract-num rid="cn006">81903483</contract-num>
<contract-sponsor id="cn001">National Key Research and Development Program of China<named-content content-type="fundref-id">10.13039/501100012166</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Key Technology Research and Development Program of Shandong<named-content content-type="fundref-id">10.13039/100014103</named-content>
</contract-sponsor>
<contract-sponsor id="cn005">Taishan Scholar Foundation of Shandong Province<named-content content-type="fundref-id">10.13039/501100010029</named-content>
</contract-sponsor>
<contract-sponsor id="cn006">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Ergot alkaloids (EA) are a class of natural products known for their extensive pharmacologic activities (<xref ref-type="bibr" rid="B28">Wallwey and Li, 2011</xref>; <xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>; <xref ref-type="bibr" rid="B13">Jakubczyk et al., 2014</xref>). They are structurally similar to dopamine, serotonin and adrenaline, and exhibit neurotoxicity by acting on the neurotransmitter receptors of tryptamine derivatives (<xref ref-type="bibr" rid="B17">Mantegani et al., 1999</xref>; <xref ref-type="bibr" rid="B16">Liu and Jia, 2017</xref>). Many natural and semi-synthetic ergot alkaloids, such as ergometrine, nicergoline and cabergoline, have been developed as important clinical drugs to treat <italic>postpartum</italic> hemorrhages, Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease and other disorders (<xref ref-type="bibr" rid="B4">Baskys and Hou, 2007</xref>; <xref ref-type="bibr" rid="B21">Perez-Lloret and Rascol, 2010</xref>; <xref ref-type="bibr" rid="B23">Robinson and Panaccione, 2015</xref>). As an important pharmaceutical intermediate, LA is applied to the industrial production of nicergoline, cabergoline and dihydroergotamine. And LA derivatives, such as lysergic acid diethylamide (LSD), have been widely used in the therapy of psychiatric diseases (<xref ref-type="bibr" rid="B32">Young et al., 2015</xref>; <xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>). Due to high demand in the market, up to 10&#x2013;15 tons of LA have been produced annually (<xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>; <xref ref-type="bibr" rid="B30">Wong et al., 2022</xref>). However, the current industrial production of LA shows low production efficiency and high cost. There is no sophisticated scheme to directly produce LA in the current industry. All the LA is acquired from alkali hydrolysis of ergometrine. About 40%&#x2013;50% of ergometrine is obtained from the parasitic production of ergot on rye (field cultivation), which highly depends on the climate and growth conditions of the host (<xref ref-type="bibr" rid="B26">Tudzynski et al., 2001</xref>). The rest of ergometrine has been contributed by the submerged fermentation using <italic>Claviceps paspali</italic> (<xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>; <xref ref-type="bibr" rid="B30">Wong et al., 2022</xref>). Complicated post-processing and separation severely restrict the yield. Hence, efficient LA-producing cell factories are urgently needed to improve the production efficiency in industry.</p>
<p>In <italic>Claviceps</italic>, the biosynthetic pathway of EA is broadly classified into three parts (<xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>). Firstly, the biosynthesis of chanoclavine-I-aldehyde, the common steps in all EA-producing species, requires five enzymes including DmaW, EasF, EasC, EasE, and EasD (<xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="B30">Wong et al., 2022</xref>). Then, the introduction of EasA, EasG, and CloA can result in the formation of LA from chanoclavine-I-aldehyde (<xref ref-type="bibr" rid="B22">Robinson and Panaccione, 2014</xref>; <xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>). Finally, LA is activated by LpsB and converted into ergoamides by LpsC (<xref ref-type="bibr" rid="B7">Correia et al., 2003</xref>; <xref ref-type="bibr" rid="B20">Ortel and Keller, 2009</xref>; <xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>). Progress in ergot alkaloid biosynthesis provides new clues for the construction of LA-producing cell factories (<xref ref-type="fig" rid="F1">Figure 1</xref>)(<xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>). Wong <italic>et al.</italic> reconstituted the LA biosynthetic pathway in <italic>Saccharomyces cerevisiae</italic> and screened the key enzymes for functional expression from different sources, constructing a LA-producing strain with 1.7&#xa0;mg&#x00B7;L<sup>&#x2212;1</sup> titer after 5&#xa0;days culture in a 1&#xa0;L bioreactor (<xref ref-type="bibr" rid="B30">Wong et al., 2022</xref>). Yao <italic>et al.</italic> expressed the key genes involved in EA biosynthesis in heterologous host <italic>Aspergillus nidulans</italic>, yielding trace amounts of LA (<xref ref-type="bibr" rid="B31">Yao et al., 2022</xref>). Besides, other engineered heterologous LA-producing strains, for instance, <italic>Metarhizium brunneum</italic>, <italic>Neosartorya fumigate</italic>, and <italic>Aspergillus fumigatus</italic>, were constructed with low titer (<xref ref-type="bibr" rid="B22">Robinson and Panaccione, 2014</xref>; <xref ref-type="bibr" rid="B3">Arnold and Panaccione, 2017</xref>; <xref ref-type="bibr" rid="B9">Davis et al., 2020</xref>; <xref ref-type="bibr" rid="B31">Yao et al., 2022</xref>). However, LA production in the above heterogeneous cell factories cannot meet actual industrial demand. It has been reported that some of the enzymes involved in the biosynthetic pathway of EA were poorly expressed in heterologous host (<xref ref-type="bibr" rid="B8">Coyle et al., 2010</xref>; <xref ref-type="bibr" rid="B19">Nielsen et al., 2014</xref>; <xref ref-type="bibr" rid="B30">Wong et al., 2022</xref>), hampering the improvement of the production. Thus, we turn to the metabolic engineering of industrial strains <italic>C. paspali</italic> MJXA-WT with high-yield ergometrine, which may avoid the incompatibility of expression elements and heterologous host. The genetic transformation method for the genus <italic>Claviceps</italic> has been reported over the past decades (<xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>). Protoplast-mediated transformation is the most popular method for the genetic transformation of <italic>Claviceps</italic>. A successful transformation method for <italic>Claviceps purpurea</italic> based on the protoplast preparation was first described in 1989 (<xref ref-type="bibr" rid="B27">van Engelenburg et al., 1989</xref>). And the conditions of protoplast formation and regeneration were further optimized (<xref ref-type="bibr" rid="B6">Comino et al., 1989</xref>; <xref ref-type="bibr" rid="B24">Smit and Tudzynski, 1992</xref>; <xref ref-type="bibr" rid="B18">Mey et al., 2002</xref>; <xref ref-type="bibr" rid="B29">Wang et al., 2016</xref>). Besides, the <italic>Agrobacterium tumefaciens</italic>-mediated transformation method for <italic>C. purpurea</italic> has been attempted, but no successful procedure has been described (<xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>). However, there are few reports on the genetic transformation for <italic>C. paspali</italic>. Engelenburg <italic>et al.</italic> developed a protoplast-mediated transformation system for <italic>C. purpurea</italic>, while suffering from low protoplast regeneration efficiency when applied to <italic>C. paspali</italic> (<xref ref-type="bibr" rid="B27">van Engelenburg et al., 1989</xref>; <xref ref-type="bibr" rid="B14">Koz&#xe1;k et al., 2018</xref>). The <italic>Agrobacterium tumefaciens</italic>-mediated transformation system had been successfully applied in <italic>C. paspali</italic>, which is operational complexity and time consuming (<xref ref-type="bibr" rid="B14">Koz&#xe1;k et al., 2018</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The complete biosynthetic and metabolic pathways of LA in <italic>C. paspali.</italic>
</p>
</caption>
<graphic xlink:href="fbioe-10-1093402-g001.tif"/>
</fig>
<p>The lack of genetic tools of <italic>C. paspali</italic> hindered the process of constructing high-yield strains through metabolic engineering. In this study, we established an effective system of genetic manipulation in the industrial strain of <italic>C. paspali</italic> MJXA-WT in the first step. Based on this, the <italic>lpsB</italic> gene was deleted in <italic>C. paspali</italic>, leading to the accumulation of LA and ILA in mutants. Finally, the fermentation process was developed and optimized for the engineered strain in shaking flasks.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Microorganism and culture conditions</title>
<p>
<italic>C. paspali</italic> MJXA-WT is an industrial ergometrine-producing strain frozen at &#x2212;80&#xb0;C in our lab at Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academic of Science, China. The strains were maintained on PDA (39&#xa0;g&#x00B7;L<sup>&#x2212;1</sup> PDA dry powder, BD company) at 25&#xb0;C for 6&#xa0;days, and then 3&#xa0;cm<sup>2</sup> fresh mycelium from the PDA plates was transferred to a 250-mL flask containing 25&#xa0;mL of seed medium (20&#xa0;g&#xb7;L<sup>&#x2212;1</sup> mannitol, 10&#xa0;g&#xb7;L<sup>&#x2212;1</sup> succinic acid, 2&#xa0;g&#xb7;L<sup>&#x2212;1</sup> soybean cake powder, 1&#xa0;g&#xb7;L<sup>&#x2212;1</sup> KH<sub>2</sub>PO<sub>4</sub>, 0.3&#xa0;g&#xb7;L<sup>&#x2212;1</sup> MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O, and pH 5.0) and cultured for 4&#xa0;days at 25&#xb0;C, 220&#xa0;rpm. The seed liquid was inoculated into 250-mL flask containing 25&#xa0;mL of fermentation medium (100&#xa0;g&#xb7;L<sup>&#x2212;1</sup> sorbitol, 35&#xa0;g&#xb7;L<sup>&#x2212;1</sup> succinic acid, 20&#xa0;g&#xb7;L<sup>&#x2212;1</sup> corn steep powder, 0.5&#xa0;g&#xb7;L<sup>&#x2212;1</sup> yeast extract powder, 0.022&#xa0;g&#xb7;L<sup>&#x2212;1</sup> FeSO<sub>4</sub>&#xb7;7H<sub>2</sub>O, 0.01&#xa0;g&#xb7;L<sup>&#x2212;1</sup> ZnSO<sub>4</sub>&#xb7;7H<sub>2</sub>O, 0.7&#xa0;g&#xb7;L<sup>&#x2212;1</sup> MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O, pH 5.5). The flasks were kept in the dark for 12&#xa0;days at 25&#xb0;C, 220&#xa0;rpm. An inoculum ratio of 15% (v/v) was used in all bioprocess. All the experiments were repeated three times in this study.</p>
</sec>
<sec id="s2-2">
<title>2.2 DNA manipulation for cassettes construction</title>
<p>Primers used in this study are listed in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. To knock out gene <italic>lpsB</italic>, primer pairs Up-lpsB-F/Up-lpsB-hph-R and Down-lpsB-hph-F/Down-lpsB-R were used to amplify the flanking 5&#x27; and 3&#x27; DNA of the <italic>lpsB</italic> gene from the genome of <italic>C. paspali</italic> MJXA-WT. The resulting DNA fragments were fused with the <italic>hph</italic> marker by fusion PCR. Primers N-lpsB-F/N-lpsB-R were used to amplify the gene-targeting cassette.</p>
</sec>
<sec id="s2-3">
<title>2.3 Protoplast-mediated transformation</title>
<p>About 3&#xa0;cm<sup>2</sup> of fresh mycelium from the PDA plates was crushed and inoculated into 100&#xa0;mL of PDB medium and cultured for 3&#x2013;4&#xa0;days at 25&#xb0;C, 220&#xa0;rpm. The mycelium was collected by filtering with sterile 300 mesh nylon cloth, and washed twice with 0.7&#xa0;M KCl solution. The mycelium was immersed in the enzymatic solution (0.1% of lywallzyme), and incubated at 30&#xb0;C for 1&#xa0;h to prepare protoplasts. The culture solution was filtered with 500 mesh nylon cloth and centrifuged for 12&#xa0;min at 4,000&#xa0;rpm to obtain protoplasts. The protoplasts were resuspended with 10&#xa0;mL of STC solution (0.85&#xa0;M sorbitol, 10 Tris-HCl pH 8.0, 50&#xa0;mM CaCl<sub>2</sub>), and centrifuged for 10&#xa0;min at 3,400&#xa0;rpm. The precipitation of protoplasts was diluted to 10<sup>7</sup> cells/mL. Then 2&#x2013;4&#xa0;&#x3bc;g of DNA fragments, 100&#xa0;&#x3bc;L protoplast solution and 50&#xa0;&#x3bc;L of ice-cold PSTC (25% PEG 6000, 1&#xa0;M D-sorbitol, 10&#xa0;mM Tris-HCl pH 8.0, and 50&#xa0;mM CaCl<sub>2</sub>) were mixed, and incubated on ice for 25&#xa0;min. After that, 1&#xa0;mL of PSTC was added and incubated for 20&#xa0;min. Afterwards, 20&#xa0;mL of liquid top agar (PDB with 0.5% agarose and 0.4&#xa0;M D-sorbitol) was added and the mixture was spread on PDAS (PDA with 0.4&#xa0;M D-sorbitol). The plates were cultured in the dark for 7&#xa0;days at 30&#xa0;C.</p>
</sec>
<sec id="s2-4">
<title>2.4 HPLC analysis</title>
<p>LA and ILA were analyzed by high-performance liquid chromatography (HPLC) equipped with a C18 reversed-phase column (Agilent, 4.6 &#xd7; 150&#xa0;mm, 5&#xa0;&#x3bc;m). 1&#xa0;mL of fermentation supernatant was extracted with 4&#xa0;mL of mixed solvent containing acetonitrile and water (1:1, v/v) for HPLC and LC-MS measurement. The mobile phases were as follows: water with 0.1% (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> (solvent A); and 75% acetonitrile (solvent B). Chromatography was carried out over a flow rate of 1.2&#xa0;mL/min, with a stepped gradient as follows: 13%&#x2013;43% B from 0&#x2013;12&#xa0;min, 43% B for 1&#xa0;min, 13% B for 1&#xa0;min. LA and ILA were quantified by comparing peak areas to standard curves under 254&#xa0;nm. The titers of LA and ILA were quantified by HPLC according to the calibration curves respectively. The calibration curves were presented as <xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>.</p>
</sec>
<sec id="s2-5">
<title>2.5 Plackett-Burman design (PBD) of the experiment</title>
<p>To determine the significant factors influencing the LA and ILA titer in submerged fermentation, six factors including inoculum amount (A), succinic acid (B), corn steep powder (C), yeast extract (D), sorbitol (E), and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O (F) were handpicked for PBD. The final titer of total lysergic acid (TLA), including LA and ILA, was chosen as the response. For each independent factor, there were high (&#x2b;1) and low (&#x2212;1) levels, which were determined based on the single factor experiment, and used to assess the influence of each factor. The coded level and actual level of each factor are listed in <xref ref-type="table" rid="T1">Table 1</xref>. All experiments were repeated three times.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>PBD for the evaluation of the factors influencing TLA titer.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Code factors</th>
<th rowspan="2" align="center">Factors</th>
<th colspan="2" align="center">Coded level and actual level</th>
</tr>
<tr>
<th align="center">&#x2212;1</th>
<th align="center">&#x2b;1</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">A</td>
<td align="center">Inoculum amount (mL)</td>
<td align="center">3</td>
<td align="center">5</td>
</tr>
<tr>
<td align="center">B</td>
<td align="center">Succinic acid (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">25</td>
<td align="center">45</td>
</tr>
<tr>
<td align="center">C</td>
<td align="center">Corn steep powder (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">10</td>
<td align="center">30</td>
</tr>
<tr>
<td align="center">D</td>
<td align="center">Yeast extract (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">0</td>
<td align="center">0.5</td>
</tr>
<tr>
<td align="center">E</td>
<td align="center">Sorbitol (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">100</td>
<td align="center">140</td>
</tr>
<tr>
<td align="center">F</td>
<td align="center">MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">1</td>
<td align="center">2</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-6">
<title>2.6 Box-Behnken design (BBD) of the experiment</title>
<p>The most monumental factors were chosen to identify their optimal level with the LA and ILA titer as the response. Three significant factors identified by PBD were corn steep powder (A), succinic acid (B) and yeast extract (C). For each variable, there were low (&#x2212;1), middle (0) and high (&#x2b;1) levels. The coded level and actual level of three factors is listed in <xref ref-type="table" rid="T2">Table 2</xref>. All the experiments were repeated three times.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>BBD for the evaluation of the factors influencing TLA titer.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Code factors</th>
<th rowspan="2" align="center">Factors</th>
<th colspan="3" align="center">Coded level and actual level</th>
</tr>
<tr>
<th align="center">-1</th>
<th align="center">0</th>
<th align="center">&#x2b;1</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">A</td>
<td align="center">Corn steep powder (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">10</td>
<td align="center">20</td>
<td align="center">30</td>
</tr>
<tr>
<td align="center">B</td>
<td align="center">Succinic acid (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">25</td>
<td align="center">35</td>
<td align="center">45</td>
</tr>
<tr>
<td align="center">C</td>
<td align="center">Yeast extract (g&#x00B7;L<sup>&#x2212;1</sup>)</td>
<td align="center">0</td>
<td align="center">0.25</td>
<td align="center">0.5</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Development of genetic manipulation system in <italic>C. paspali</italic>
</title>
<p>Inefficient genetic manipulation system restricted metabolic engineering of <italic>C. paspali</italic>. Protoplast-mediated transformation is widely and efficiently used in ascomycetes transformation. Therefore, we choose this method to establish the genetic manipulation system in <italic>C. paspali</italic>. As an industrial strain, <italic>C. paspali</italic> MJXA-WT lost the sporulation ability, the mycelium from PDA plates was used as seeds for cultivation of mycelium. Poor mycelium leads to difficulties in protoplast preparation and low efficiency of cell wall regeneration. Homologous recombination usually occurs in logarithmic growth period. The regeneration efficiency was mainly depended on the culture time of mycelia. We tried to apply the mycelia of non-sporulating <italic>C. paspali</italic> MJXA-WT cultured in original medium for different time to transformation. However, it showed very low regeneration efficiency probably due to the slow growth state. Luckily, we found that the mycelia of <italic>C. paspali</italic> MJXA-WT grew very fast only in the PDB medium, and the hyphae of <italic>C. paspali</italic> MJXA-WT cultivated in PDB medium for 3-days was applied to the enzymatic digestion in next step. Enzyme solution of 0.1% lywallzyme was used to digest cell wall, which produced 1.0 &#xd7; 10<sup>6</sup> cells/mL at 30&#xb0;C in an hour or so. STC solution was used to wash and resuspend the protoplasts at 1.0 &#xd7; 10<sup>7</sup> cells/mL. In the PEG-CaCl<sub>2</sub> mediated transformation, 2&#x2013;4&#xa0;&#x3bc;g of DNA fragments, a cassette containing <italic>PgpdAt</italic> (constitutive promoter of glyceraldehyde-3-phosphate dehydrogenase from <italic>Aspergillus terreus</italic>), <italic>sgfp</italic> (synthetic green fluorescent protein), <italic>TtrpC</italic> (terminator of tryptophan synthetase from <italic>Aspergillus nidulans</italic>) and <italic>hph</italic> (hygromycin B phosphotransferase gene), was added in 100&#xa0;&#x3bc;L protoplasts solution. The D-sorbitol concentration of regeneration medium was optimized, and the optimal concentration was 0.4&#xa0;M (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). Beginning with 1.0 &#xd7; 10<sup>7</sup> protoplasts, approximately 120&#x2013;150 positive clones were obtained in a reaction (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>). Transformants were verified by genomic PCR. The representative mutant strains displayed significant green fluorescence under the fluorescence microscope, while the parental strain did not show any visible fluorescence (<xref ref-type="fig" rid="F2">Figure 2</xref>). Consequently, an efficient genetic manipulation system, which was based on the protoplast-mediated transformation, was established in the industrial strain <italic>C. paspali</italic> MJXA-WT.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Microscopic features of wild-type and mutant strains. Bright: Bright-field images. GFP: Fluorescence images.</p>
</caption>
<graphic xlink:href="fbioe-10-1093402-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Construction of the LA-producing cell factory</title>
<p>The gene <italic>lpsB</italic> was involved in the modification of LA in the biosynthetic pathway of ergometrine (<xref ref-type="fig" rid="F1">Figure 1</xref>). We tried to knock out <italic>lpsB</italic> to prevent the biosynthesis of ergometrine, resulting in the accumulation of LA. The targeting element was constructed using <italic>hph</italic> as a marker. About 1&#xa0;kb region in <italic>lpsB</italic> gene was replaced by the <italic>hph</italic> (2.2&#xa0;kb) (<xref ref-type="fig" rid="F3">Figure 3A</xref>). As shown in <xref ref-type="fig" rid="F3">Figure 3B</xref>, the <italic>lpsB</italic> gene was successfully disrupted in mutant strains (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Knocking out <italic>lpsB</italic> eliminated the production of ergometrine but accumulated two new products with identical molecular ion peaks ([M &#x2b; H]<sup>&#x2b;</sup> 269.1303) (<xref ref-type="fig" rid="F3">Figure 3C</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). The new products were identified as LA and ILA by further NMR analyses (<xref ref-type="sec" rid="s10">Supplementary Figures S4, 5</xref>) (<xref ref-type="bibr" rid="B15">Liu and Jia, 2011</xref>). The <sup>1</sup>H and <sup>13</sup>C NMR data of ILA showed quite similar signals to those of LA. The noticeable differences were the occurrence of C-8 (&#x3b4;C 42.7, &#x3b4;H 3.54&#x2013;3.50) in ILA, rather than C-8 (&#x3b4;C 44.4, &#x3b4;H 4.09&#x2013;4.04) carbons in LA. <xref ref-type="sec" rid="s10">Supplementary Table S3</xref> indicated the attribution of <sup>1</sup>H and <sup>13</sup>C NMR data for LA and ILA. Due to its instability, LA could be partially converted to its isomer ILA (<xref ref-type="bibr" rid="B25">Stoll et al., 1949</xref>; <xref ref-type="bibr" rid="B11">Himmelsbach et al., 2014</xref>; <xref ref-type="bibr" rid="B31">Yao et al., 2022</xref>). The percentages of LA were stabilized at around 45%, while the percentages of ILA were stabilized at around 55%. Base on this, we used the titer of TLA to evaluate the change of production in the next step.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Construction of the LA-producing cell factory. <bold>(A)</bold> Strategy for deleting <italic>lpsB</italic> gene in <italic>C. paspali</italic> MJXA-WT. <bold>(B)</bold> Genotype verification. Lane M: 1&#xa0;kb DNA marker; lane WT: <italic>C. paspali</italic> MJXA-WT; lane <italic>&#x394;lpsB</italic>: parent strain <italic>C. paspali</italic> MJXA-<italic>&#x394;lpsB-hph</italic>. <bold>(C)</bold> HPLC analysis of wild-type and mutant strains.</p>
</caption>
<graphic xlink:href="fbioe-10-1093402-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Effects of initial media components on LA and ILA accumulation</title>
<p>Since various factors in the fermentation medium affect the titer of TLA, an effective experimental approach, such as Plackett-Burman and Box-Behnken design, is essential to achieve the optimal production. First, single-factor experiments were selected to assess the influence of inoculum amount and five key components of the medium (succinic acid, corn steep powder, yeast extract, sorbitol, and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O) on the titer of TLA. The influence of different inoculum amount on the titer of TLA was shown in <xref ref-type="fig" rid="F4">Figure 4A</xref>. With the increase of inoculum amount, the titer of TLA improved. The highest titre was obtained when the inoculum amount was 4&#xa0;mL, reaching 0.83&#xa0;g&#x00B7;L<sup>&#x2212;1</sup>. The production curve of the titer of TLA tended to flatten when the inoculum amount was more than 4&#xa0;mL. The effect of succinic acid with the addition between 25&#xa0;g&#xb7;L<sup>&#x2212;1</sup> to 45&#xa0;g&#xb7;L<sup>&#x2212;1</sup> was not significant (<xref ref-type="fig" rid="F4">Figure 4B</xref>), the production was highest when the concentration was 35&#xa0;g&#xb7;L<sup>&#x2212;1</sup>. A high titer of TLA was obtained with 20&#xa0;g&#xb7;L<sup>&#x2212;1</sup> corn steep powder added, while the titer of TLA decreased when the corn steep powder concentration was further increased (<xref ref-type="fig" rid="F4">Figure 4C</xref>). When the concentration of yeast extract was 0.25&#xa0;g&#xb7;L<sup>&#x2212;1</sup>, the titer of TLA reached the maximum, and then decreased significantly with the increase of yeast extract content (<xref ref-type="fig" rid="F4">Figure 4D</xref>). Increasing sorbitol and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O concentrations enhanced the titer of TLA. A maximum titer of TLA of 1.09&#xa0;g&#xb7;L<sup>&#x2212;1</sup> and 1.23&#xa0;g&#xb7;L<sup>&#x2212;1</sup> was achieved when sorbitol and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O were added in the medium with the concentration of 120&#xa0;g&#xb7;L<sup>&#x2212;1</sup> and 1.5&#xa0;g&#xa0;L<sup>&#x2212;1</sup>, respectively (<xref ref-type="fig" rid="F4">Figures 4E, F</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of inoculation amount <bold>(A)</bold> and initial medium components of succinic acid <bold>(B)</bold>, corn steep powder <bold>(C)</bold>, yeast extract <bold>(D)</bold>, sorbitol <bold>(E)</bold> and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O <bold>(F)</bold> on LA and ILA accumulation. Lowercase alphabets indicate that the values are statistically significant with corresponding <italic>p</italic>-values less than 0.05.</p>
</caption>
<graphic xlink:href="fbioe-10-1093402-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Identification of significant factors using PBD</title>
<p>PBD, a two-level experimental design (<xref ref-type="bibr" rid="B1">Abdel-Fattah et al., 2005</xref>; <xref ref-type="bibr" rid="B2">Abuhena et al., 2022</xref>), was further used to screen out the crucial factors which have a significant impact on the titer of TLA. The experimental data were shown in <xref ref-type="table" rid="T3">Table 3</xref>. And analysis of experimental results was listed in <xref ref-type="table" rid="T4">Table 4</xref> using Design Expert 12.0 software. As the F-value was 27.85 and the <italic>p</italic>-value of 0.0011 was less than 0.05, the model was significant. Two factors, succinic acid and yeast extract were identified as the significant factors influencing the titer of TLA, with corresponding <italic>p</italic>-values less than 0.05. The corresponding <italic>p</italic>-values of corn steep powder was less than 0.001, implying that it was highly significant. Others factors, inoculum amount, sorbitol and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O, with corresponding <italic>p</italic>-values more than 0.1, implied that they were not significant. Another important evaluation indicator of the model quality is R<sup>2</sup>. The values of R<sup>2</sup>, predicated R<sup>2</sup> and adjusted R<sup>2</sup> were 0.9709, 0.9361, and 0.8327, respectively, indicating that the predicted model was highly fit and effective. The final equation in terms of actual factors was derived as follows:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>Y</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1.903</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.009</mml:mn>
<mml:mi>A</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.256</mml:mn>
<mml:mi>B</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.363</mml:mn>
<mml:mi>C</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.218</mml:mn>
<mml:mi>D</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.051</mml:mn>
<mml:mi>E</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.006</mml:mn>
<mml:mi>F</mml:mi>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>PBD factors affecting the titer of TLA.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Run order</th>
<th align="center">A</th>
<th align="center">B</th>
<th align="center">C</th>
<th align="center">D</th>
<th align="center">E</th>
<th align="center">F</th>
<th align="center">Response</th>
</tr>
<tr>
<th align="center">Inoculum size</th>
<th align="center">Succinic acid</th>
<th align="center">Corn steep powder</th>
<th align="center">Yeast extract</th>
<th align="center">Sorbitol</th>
<th align="center">MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O</th>
<th align="center">Titer of TLA (g&#xb7;L<sup>-1</sup>)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1.36 &#xb1; 0.05</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1.56 &#xb1; 0.01</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">2.19 &#xb1; 0.10</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1.08 &#xb1; 0.04</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">2.94 &#xb1; 0.05</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">2.20 &#xb1; 0.01</td>
</tr>
<tr>
<td align="center">7</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">2.57 &#xb1; 0.02</td>
</tr>
<tr>
<td align="center">8</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1.87 &#xb1; 0.02</td>
</tr>
<tr>
<td align="center">9</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1.60 &#xb1; 0.03</td>
</tr>
<tr>
<td align="center">10</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">1.54 &#xb1; 0.01</td>
</tr>
<tr>
<td align="center">11</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1.82 &#xb1; 0.01</td>
</tr>
<tr>
<td align="center">12</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">2.10 &#xb1; 0.06</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>ANOVA of PBD with F and <italic>p</italic> values.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Source</th>
<th align="center">Sum of squares</th>
<th align="center">Degrees of freedom</th>
<th align="center">Mean square</th>
<th align="center">F-value</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Model</td>
<td align="center">2.9624</td>
<td align="center">6</td>
<td align="center">0.4937</td>
<td align="center">27.85</td>
<td align="center">0.0011</td>
</tr>
<tr>
<td align="center">A-Inoculum amount</td>
<td align="center">0.0010</td>
<td align="center">1</td>
<td align="center">0.0010</td>
<td align="center">0.06</td>
<td align="center">0.8210</td>
</tr>
<tr>
<td align="center">B-Succinic acid</td>
<td align="center">0.7854</td>
<td align="center">1</td>
<td align="center">0.7854</td>
<td align="center">44.30</td>
<td align="center">0.0012</td>
</tr>
<tr>
<td align="center">C-Corn steep powder</td>
<td align="center">1.5769</td>
<td align="center">1</td>
<td align="center">1.5769</td>
<td align="center">88.95</td>
<td align="center">0.0002</td>
</tr>
<tr>
<td align="center">D-Yeast extract</td>
<td align="center">0.5677</td>
<td align="center">1</td>
<td align="center">0.5677</td>
<td align="center">32.02</td>
<td align="center">0.0024</td>
</tr>
<tr>
<td align="center">E-Sorbitol</td>
<td align="center">0.0310</td>
<td align="center">1</td>
<td align="center">0.0310</td>
<td align="center">1.75</td>
<td align="center">0.2433</td>
</tr>
<tr>
<td align="center">F-MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O</td>
<td align="center">0.0004</td>
<td align="center">1</td>
<td align="center">0.0004</td>
<td align="center">0.02</td>
<td align="center">0.8853</td>
</tr>
<tr>
<td align="center">Residual</td>
<td align="center">0.0886</td>
<td align="center">5</td>
<td align="center">0.0177</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center">Total</td>
<td align="center">3.0510</td>
<td align="center">11</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<p>According to the regression coefficient, four factors (inoculum amount, succinic acid, yeast extract and sorbitol) showed positive effects on the titer of TLA. Besides, succinic acid and MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O showed negative effects. Succinic acid, corn steep powder, and yeast extract were chosen as key factors for further optimization. Succinic acid in the tricarboxylic acid cycle was usually used as a carbon source, which may promote the high level of oxidative metabolism in the <italic>Claviceps</italic> cells, promoting the biosynthesis of secondary metabolites (<xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>). Fermentation nitrogen (corn steep powder and yeast extract) are particularly rich in protein and amino acid, such as tryptophan and methionine, which may promote the synthesis of ergot alkaloids (<xref ref-type="bibr" rid="B12">Hulvov&#xe1; et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>).</p>
</sec>
<sec id="s3-5">
<title>3.5 Optimization of culture medium using BBD</title>
<p>BBD is a reliable method which is usually used to identify the optimum response region for significant factors (<xref ref-type="bibr" rid="B10">Hegazy et al., 2022</xref>). In this study, three significant factors (corn steep powder, (A); succinic acid, (B); yeast extract, (C)) were further explored at three levels. The experimental data were shown in <xref ref-type="table" rid="T5">Table 5</xref>. And analysis of experimental results was listed in <xref ref-type="table" rid="T6">Table 6</xref> using Design Expert 12.0 software. As the F-value was 271.56 and the <italic>p</italic>-value was less than 0.0001, the model was highly significant. The corresponding <italic>p</italic>-values of A, B, and C were both less than 0.0001, suggesting that these factors were highly significant. In the same light, the corresponding <italic>p</italic>-values of A<sup>2</sup>, B<sup>2</sup>, and C<sup>2</sup> were both less than 0.0001. The values of R<sup>2</sup>, predicated R<sup>2</sup> and adjusted R<sup>2</sup> were 0.9971, 0.9935, and 0.9731, respectively, indicating that the model was effective and reliable. To predict the optimal point, the final equation fitted to the experimental response results was represented below:<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>Y</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>3.38</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.36</mml:mn>
<mml:mi>A</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.301</mml:mn>
<mml:mi>B</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.414</mml:mn>
<mml:mi>C</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.055</mml:mn>
<mml:mi>A</mml:mi>
<mml:mi>B</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.135</mml:mn>
<mml:mi>A</mml:mi>
<mml:mi>C</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.113</mml:mn>
<mml:mi>B</mml:mi>
<mml:mi>C</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.703</mml:mn>
<mml:msup>
<mml:mi>A</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.615</mml:mn>
<mml:msup>
<mml:mi>B</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.525</mml:mn>
<mml:msup>
<mml:mi>C</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>BBD for factors affecting the titer of TLA.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Run order</th>
<th align="center">A</th>
<th align="center">B</th>
<th align="center">C</th>
<th align="center">Response</th>
</tr>
<tr>
<th align="center">Corn steep powder</th>
<th align="center">Succinic acid</th>
<th align="center">Yeast extract</th>
<th align="center">Titer of TLA (g&#xb7;L<sup>-1</sup>)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">1</td>
<td align="center">3.09 &#xb1; 0.00</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">0</td>
<td align="center">1.49 &#xb1; 0.00</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">3.41 &#xb1; 0.00</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">&#x2212;1</td>
<td align="center">0</td>
<td align="center">&#x2212;1</td>
<td align="center">1.48 &#xb1; 0.02</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">0</td>
<td align="center">2.02 &#xb1; 0.01</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">3.34 &#xb1; 0.04</td>
</tr>
<tr>
<td align="center">7</td>
<td align="center">0</td>
<td align="center">1</td>
<td align="center">&#x2212;1</td>
<td align="center">2.00 &#xb1; 0.03</td>
</tr>
<tr>
<td align="center">8</td>
<td align="center">0</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;1</td>
<td align="center">1.63 &#xb1; 0.03</td>
</tr>
<tr>
<td align="center">9</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">3.03 &#xb1; 0.13</td>
</tr>
<tr>
<td align="center">10</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">2.74 &#xb1; 0.00</td>
</tr>
<tr>
<td align="center">11</td>
<td align="center">0</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">2.25 &#xb1; 0.00</td>
</tr>
<tr>
<td align="center">12</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">3.36 &#xb1; 0.00</td>
</tr>
<tr>
<td align="center">13</td>
<td align="center">0</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">3.07 &#xb1; 0.01</td>
</tr>
<tr>
<td align="center">14</td>
<td align="center">&#x2212;1</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">1.99 &#xb1; 0.07</td>
</tr>
<tr>
<td align="center">15</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">3.44 &#xb1; 0.05</td>
</tr>
<tr>
<td align="center">16</td>
<td align="center">&#x2212;1</td>
<td align="center">0</td>
<td align="center">1</td>
<td align="center">2.02 &#xb1; 0.03</td>
</tr>
<tr>
<td align="center">17</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">&#x2212;1</td>
<td align="center">2.01 &#xb1; 0.02</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Analysis of variance for regression model of LA and ILA production.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Source</th>
<th align="center">Sum of squares</th>
<th align="center">Degrees of freedom</th>
<th align="center">Mean square</th>
<th align="center">F-value</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Model</td>
<td align="center">8.66</td>
<td align="center">9</td>
<td align="center">0.9623</td>
<td align="center">271.56</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">A</td>
<td align="center">1.04</td>
<td align="center">1</td>
<td align="center">1.04</td>
<td align="center">292.59</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">B</td>
<td align="center">0.726</td>
<td align="center">1</td>
<td align="center">0.726</td>
<td align="center">204.88</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">C</td>
<td align="center">1.37</td>
<td align="center">1</td>
<td align="center">1.37</td>
<td align="center">386.48</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">AB</td>
<td align="center">0.0121</td>
<td align="center">1</td>
<td align="center">0.0121</td>
<td align="center">3.41</td>
<td align="center">0.1071</td>
</tr>
<tr>
<td align="center">AC</td>
<td align="center">0.0729</td>
<td align="center">1</td>
<td align="center">0.0729</td>
<td align="center">20.57</td>
<td align="center">0.0027</td>
</tr>
<tr>
<td align="center">BC</td>
<td align="center">0.0506</td>
<td align="center">1</td>
<td align="center">0.0506</td>
<td align="center">14.29</td>
<td align="center">0.0069</td>
</tr>
<tr>
<td align="center">A<sup>2</sup>
</td>
<td align="center">2.08</td>
<td align="center">1</td>
<td align="center">2.08</td>
<td align="center">586.81</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">B<sup>2</sup>
</td>
<td align="center">1.59</td>
<td align="center">1</td>
<td align="center">1.59</td>
<td align="center">449.78</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">C<sup>2</sup>
</td>
<td align="center">1.16</td>
<td align="center">1</td>
<td align="center">1.16</td>
<td align="center">327.81</td>
<td align="center">&#x3c;0.0001</td>
</tr>
<tr>
<td align="center">Residual</td>
<td align="center">0.0248</td>
<td align="center">7</td>
<td align="center">0.0035</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center">Lack of Fit</td>
<td align="center">0.0135</td>
<td align="center">3</td>
<td align="center">0.0045</td>
<td align="center">1.6</td>
<td align="center">0.3227</td>
</tr>
<tr>
<td align="center">Pure Error</td>
<td align="center">0.0113</td>
<td align="center">4</td>
<td align="center">0.0028</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center">Cor Total</td>
<td align="center">8.69</td>
<td align="center">16</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<p>According to the equation, the predicted optimum of the cultural medium consisted of 37.2&#xa0;g&#xb7;L<sup>&#x2212;1</sup> succinic acid, 23.5&#xa0;g&#xb7;L<sup>&#x2212;1</sup> corn steep liquor powder, and 0.4&#xa0;g&#xb7;L<sup>&#x2212;1</sup> yeast extract powder, and the predicated titer was 3.6&#xa0;g&#xb7;L<sup>&#x2212;1</sup>. The value of R<sup>2</sup> was 0.997, indicating a great degree of correlation between the experimental and the predicted values.</p>
<p>To better evaluate the interaction effect between three key factors, three-dimensional response surfaces and contour plots were created in <xref ref-type="fig" rid="F5">Figure 5</xref>. Based on the surface drawing and contour drawing of response surface model, <xref ref-type="fig" rid="F5">Figures 5A, B</xref> showed the interaction effect of corn steep powder and succinic acid on the titer of TLA with the concentration of yeast extract was 0.4&#xa0;g&#xb7;L<sup>-1</sup>. Increasing the corn steep powder and succinic acid to the optimal point improved the titer of TLA. However, the increased amount of both factors leaded to the decline of the titer. <xref ref-type="fig" rid="F5">Figures 5C, D</xref> showed the interaction effect of corn steep powder and yeast extract on the titer of TLA with the concentration of succinic acid was 37.2&#xa0;g&#xb7;L<sup>&#x2212;1</sup>. Increasing the addition of corn steep powder and yeast extract to the optimal point improved the titer of TLA. However, improving concentration of both factors leaded to the decline of the titer. <xref ref-type="fig" rid="F5">Figures 5E, F</xref> showed the interaction effect of succinic acid and yeast extract on the titer of TLA with the concentration of corn steep powder was 23.5&#xa0;g&#xb7;L<sup>&#x2212;1</sup>. Increasing the concentration of succinic acid and yeast extract to the optimal point improved the titer of TLA. However, improving concentration of both factors leaded to the decline of the titer.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Three-dimensional response surfaces of <bold>(A)</bold> corn steep powder and succinic acid; <bold>(C)</bold> corn steep powder and yeast extract; <bold>(E)</bold> succinic acid and yeast extract, contour plots of <bold>(B)</bold> corn steep powder and succinic acid; <bold>(D)</bold> corn steep powder and yeast extract; <bold>(F)</bold> succinic acid and yeast extract.</p>
</caption>
<graphic xlink:href="fbioe-10-1093402-g005.tif"/>
</fig>
<p>To verify the developed model, the time profile of TLA production under the optimal fermentation condition was analyzed. After 16&#xa0;days culture, the final titer of TLA reached 3.7&#xa0;g&#xb7;L<sup>&#x2212;1</sup> using the optimal fermentation medium (<xref ref-type="fig" rid="F6">Figure 6</xref>), which was close to the predicted value 3.6&#xa0;g&#xb7;L<sup>&#x2212;1</sup>. Hence, the validity of this model was verified. Whereas, the titer of TLA reached 0.8&#xa0;g&#xb7;L<sup>&#x2212;1</sup> using the original fermentation medium. It indicates that an efficient microbial fermentation technology for LA production has been developed using an engineered <italic>C. paspali</italic> strain.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>The time profile of the production of TLA using the optimal fermentation medium.</p>
</caption>
<graphic xlink:href="fbioe-10-1093402-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>In this study, an efficient genetic manipulation system, which was based on the protoplast-mediated transformation, was established in the industrial strain <italic>C. paspali</italic>. Based on this, LA and ILA were accumulated in the <italic>&#x394;lpsB</italic> strain. By single factor optimization, PBD and BBD optimization in shaking flasks, an optimal fermentation medium composition was obtained. The final titer of TLA reached 3.7&#xa0;g&#xb7;L<sup>&#x2212;1</sup>, which was 4.6-fold of that in the initial medium. Our work provides an efficient strategy for LA production, and lays the foundation for its industrial application in the future.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>XH, SC, and XL conceived the project; SC provide the parent strain of <italic>Claviceps paspali</italic>. MH, ST, and XZ performed the fungal engineering; YZ, MH, SD, and YY performed the fermentation experiments and analysed the results with the help of WZ, MH, YZ, and XZ drafted the manuscript; XH, XZ, and XL revised the manuscript. All authors read the manuscript and agree to submit to Frontiers in Bioengineering and Biotechnology.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by the National Key R&#x26;D Program of China (No. 2021YFC2102600), the National Natural Science Foundation of China (U2032139, 32170098, 81903483), Key R&#x26;D Program of Shandong Province (No. 2021ZDSYS02). XL and XH are supported by the Shandong Taishan Scholarship.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>Author YY is employed by Shisenhai (Hangzhou) Biopharmaceutical Co., Ltd.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2022.1093402/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2022.1093402/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Fattah</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Gohar</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>El-Baz</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Improved production of <italic>Pseudomonas aeruginosa</italic> uricase by optimization of process parameters through statistical experimental designs</article-title>. <source>Process. Biochem.</source> <volume>40</volume> (<issue>5</issue>), <fpage>1707</fpage>&#x2013;<lpage>1714</lpage>. <pub-id pub-id-type="doi">10.1016/j.procbio.2004.06.048</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abuhena</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Al-Rashid</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Azim</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M. N. M.</given-names>
</name>
<name>
<surname>Kabir</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Barman</surname>
<given-names>N. C. B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Optimization of industrial (3000 L) production of <italic>Bacillus subtilis</italic> CW-S and its novel application for minituber and industrial-grade potato cultivation</article-title>. <source>Sci. Rep.</source> <volume>12</volume>, <fpage>11153</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-15366-5</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Panaccione</surname>
<given-names>D. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Biosynthesis of the pharmaceutically important fungal ergot alkaloid dihydrolysergic acid requires a specialized allele of <italic>cloA</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>83</volume> (<issue>14</issue>), <fpage>e00805</fpage>&#x2013;<lpage>e00817</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00805-17</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baskys</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Vascular dementia: Pharmacological treatment approaches and perspectives</article-title>. <source>Clin. Interv. Aging.</source> <volume>2</volume> (<issue>3</issue>), <fpage>327</fpage>&#x2013;<lpage>335</lpage>.</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.-J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M.-Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.-L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Recent progress in ergot alkaloid research</article-title>. <source>RSC Adv.</source> <volume>7</volume>, <fpage>27384</fpage>&#x2013;<lpage>27396</lpage>. <pub-id pub-id-type="doi">10.1039/C7RA03152A</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kolar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>So&#x10d;i&#x10d;</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Heterologous transformation ofClaviceps purpurea</article-title>. <source>Claviceps Purpurea. Biotechnol. Lett.</source> <volume>11</volume>, <fpage>389</fpage>&#x2013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1007/BF01089469</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Grammel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ortel</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Tudzynski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular cloning and analysis of the ergopeptine assembly system in the ergot fungus <italic>Claviceps purpurea</italic>
</article-title>. <source>Chem. Biol.</source> <volume>10</volume> (<issue>12</issue>), <fpage>1281</fpage>&#x2013;<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2003.11.013</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coyle</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>O&#x27;Connor</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Panaccione</surname>
<given-names>D. G.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>An old yellow enzyme gene controls the branch point between <italic>Aspergillus fumigatus</italic> and <italic>Claviceps purpurea</italic> ergot alkaloid pathways</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>76</volume> (<issue>12</issue>), <fpage>3898</fpage>&#x2013;<lpage>3903</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02914-09</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Panaccione</surname>
<given-names>D. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Genetic reprogramming of the ergot alkaloid pathway of <italic>Metarhizium brunneum</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>86</volume> (<issue>19</issue>), <fpage>012511</fpage>&#x2013;<lpage>e1320</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01251-20</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hegazy</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Abu-Serie</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Abou-Elela</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Ghozlan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sabry</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Soliman</surname>
<given-names>N. A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Bioprocess development for biosurfactant production by <italic>Natrialba</italic> sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV</article-title>. <source>Sci. Rep.</source> <volume>12</volume> (<issue>1</issue>), <fpage>16577</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-20091-0</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Himmelsbach</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferdig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rohrer</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Analysis of paspalic acid, lysergic acid, and iso-lysergic acid by capillary zone electrophoresis with UV- and quadrupole time-of-flight mass spectrometric detection</article-title>. <source>Electrophoresis</source> <volume>35</volume> (<issue>9</issue>), <fpage>1329</fpage>&#x2013;<lpage>1333</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201300224</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hulvov&#xe1;</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Galuszka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fr&#xe9;bortov&#xe1;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fr&#xe9;bort</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Parasitic fungus <italic>Claviceps</italic> as a source for biotechnological production of ergot alkaloids</article-title>. <source>Biotechnol. Adv.</source> <volume>31</volume> (<issue>1</issue>), <fpage>79</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2012.01.005</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakubczyk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>O&#x27;Connor</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Biosynthesis of the ergot alkaloids</article-title>. <source>Nat. Prod. Rep.</source> <volume>31</volume> (<issue>10</issue>), <fpage>1328</fpage>&#x2013;<lpage>1338</lpage>. <pub-id pub-id-type="doi">10.1039/c4np00062e</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koz&#xe1;k</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Szil&#xe1;gyi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>V&#xe1;g&#xf3;</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kakuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>T&#xf3;th</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Moln&#xe1;r</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Inactivation of the indole-diterpene biosynthetic gene cluster of <italic>Claviceps paspali</italic> by <italic>Agrobacterium</italic>-mediated gene replacement</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>102</volume> (<issue>7</issue>), <fpage>3255</fpage>&#x2013;<lpage>3266</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-8807-x</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Total synthesis of (&#x2b;)-lysergic acid</article-title>. <source>Org. Lett.</source> <volume>13</volume> (<issue>18</issue>), <fpage>4810</fpage>&#x2013;<lpage>4813</lpage>. <pub-id pub-id-type="doi">10.1021/ol2018467</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Ergot alkaloids: Synthetic approaches to lysergic acid and clavine alkaloids</article-title>. <source>Nat. Prod. Rep.</source> <volume>34</volume> (<issue>4</issue>), <fpage>411</fpage>&#x2013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1039/c6np00110f</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantegani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Varasi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Ergoline derivatives: Receptor affinity and selectivity</article-title>. <source>Farmaco</source> <volume>54</volume> (<issue>5</issue>), <fpage>288</fpage>&#x2013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-827x(99)00028-2</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mey</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Held</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tenberge</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Tudzynski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>CPMK2, an SLT2-homologous mitogen-activated protein (MAP) kinase, is essential for pathogenesis of <italic>Claviceps purpurea</italic> on rye: evidence for a second conserved pathogenesis-related MAP kinase cascade in phytopathogenic fungi</article-title>. <source>Mol. Microbiol.</source> <volume>46</volume> (<issue>2</issue>), <fpage>305</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03133.x</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname>
<given-names>C. A. F.</given-names>
</name>
<name>
<surname>Folly</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hatsch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Molt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schr&#xf6;der</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>O&#x27;Connor</surname>
<given-names>S. E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The important ergot alkaloid intermediate chanoclavine-I produced in the yeast <italic>Saccharomyces cerevisiae</italic> by the combined action of EasC and EasE from <italic>Aspergillus japonicus</italic>
</article-title>. <source>Microb. Cell Fact.</source> <volume>13</volume>, <fpage>95</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-014-0095-2</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortel</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Combinatorial assembly of simple and complex D-lysergic acid alkaloid peptide classes in the ergot fungus <italic>Claviceps purpurea</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume> (<issue>11</issue>), <fpage>6650</fpage>&#x2013;<lpage>6660</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M807168200</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Lloret</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rascol</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Dopamine receptor agonists for the treatment of early or advanced Parkinson&#x27;s disease</article-title>. <source>CNS Drugs</source> <volume>24</volume> (<issue>11</issue>), <fpage>941</fpage>&#x2013;<lpage>968</lpage>. <pub-id pub-id-type="doi">10.2165/11537810-000000000-00000</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Panaccione</surname>
<given-names>D. G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Heterologous expression of lysergic acid and novel ergot alkaloids in <italic>Aspergillus fumigatus</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>80</volume> (<issue>20</issue>), <fpage>6465</fpage>&#x2013;<lpage>6472</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02137-14</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Panaccione</surname>
<given-names>D. G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Diversification of ergot alkaloids in natural and modified fungi</article-title>. <source>Toxins</source> <volume>7</volume> (<issue>1</issue>), <fpage>201</fpage>&#x2013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.3390/toxins7010201</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smit</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tudzynski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Efficient transformation of <italic>Claviceps purpurea</italic> using pyrimidine auxotrophic mutants: cloning of the OMP decarboxylase gene</article-title>. <source>Mol. Gen. Genet.</source> <volume>234</volume> (<issue>2</issue>), <fpage>297</fpage>&#x2013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1007/BF00283850</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoll</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Troxler</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1949</year>). <article-title>&#xdc;ber die Isomerie von Lysergs&#xe4;ure und Isolysergs&#xe4;ure. 14. Mitteilung &#xfc;ber Mutterkornalkaloide</article-title>. <source>Helv. Chim. Acta.</source> <volume>32</volume> (<issue>2</issue>), <fpage>506</fpage>&#x2013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1002/hlca.19490320219</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tudzynski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Biotechnology and genetics of ergot alkaloids</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>57</volume> (<issue>5-6</issue>), <fpage>593</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1007/s002530100801</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Engelenburg</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Smit</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goosen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>van den Broek</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tudzynski</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Transformation of <italic>Claviceps purpurea</italic> using a bleomycin resistance gene</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>30</volume>, <fpage>364</fpage>&#x2013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1007/BF00296625</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallwey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.-M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ergot alkaloids: Structure diversity, biosynthetic gene clusters and functional proof of biosynthetic genes</article-title>. <source>Nat. Prod. Rep.</source> <volume>28</volume> (<issue>3</issue>), <fpage>496</fpage>&#x2013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1039/c0np00060d</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.-B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.-J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Establishment of transformation system of <italic>Claviceps purpurea</italic> Cp-1 strain</article-title>. <source>Acta Pharm. Sin.</source> <volume>51</volume> (<issue>5</issue>), <fpage>828</fpage>&#x2013;<lpage>833</lpage>.</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Go</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Freemont</surname>
<given-names>P. S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Reconstituting the complete biosynthesis of D-lysergic acid in yeast</article-title>. <source>Nat. Commun.</source> <volume>13</volume> (<issue>1</issue>), <fpage>712</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-28386-6</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Overproduction of medicinal ergot alkaloids based on a fungal platform</article-title>. <source>Metab. Eng.</source> <volume>69</volume>, <fpage>198</fpage>&#x2013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2021.12.002</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Schardl</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Panaccione</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Florea</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takach</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Charlton</surname>
<given-names>N. D.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Genetics, genomics and evolution of ergot alkaloid diversity</article-title>. <source>Toxins</source> <volume>7</volume> (<issue>4</issue>), <fpage>1273</fpage>&#x2013;<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.3390/toxins7041273</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>